Sleep quality can be affected by both the autoimmune condition and, at higher doses, by GLP-1 therapy itself
Compounded oral drops require careful pharmacy and provider oversight
Smaller, more frequent portions can also be gentler if you're dealing with nausea on a GLP-1
Tirzepatides dual-action approach may provide a more comprehensive signal to the brain and metabolic system regarding fullness and energy use
For many patients, this represents the first time they've experienced meaningful, sustained fat loss after years of effort with conventional approaches
Common day 2-3 experiences include feeling full after eating much less than usual, mild to moderate nausea especially after fatty or heavy foods, some people report diarrhea while others experience constipation (it can go either direction), fatigue that feels like you did not sleep enough even though you did, and mild headaches that may be related to reduced food intake or dehydration